title: [Update hyperthyreoidism].
abstract: Hyperthyroidism is mainly caused by Graves' disease and toxic adenoma or multinodular goiter. In Europe, treatment of both disorders is usually started with antithyroidal drugs such as methimazole. Complications include agranulocytosis and the risk is dose-dependent. The starting dose of methimazole should not exceed 15-20 mg/d. Propylthiouracil can cause severe liver failure, leading to liver transplantation or death. Propylthiouracil, therefore, should not be used as first line agent and is only recommended when an antithyroid drug is to be started during the first trimester of pregnancy or in individuals who have experienced adverse responses to methimazole. Toxic adenoma is finally treated with radioioidine. To reduce the risk of treatment failure, antithyroidal drugs should be stopped at least one week prior to radioiodine. For Graves' disease, remission is unlikely if antibodies against the TSH-receptor remain above 10 mU/l after 6 months of antithyroidal treatment and radioiodine or thyroidectomy can be recommended. Thyroidectomy should be performed as (near) total thyreoidectomy.
authors.affiliation: Klinik für Endokrinologie und Zentrallabor, Bereich Forschung und Lehre, Universität Duisburg-Essen, Hufelandstrasse 55, 45122, Essen, Deutschland. lars.moeller@uk-essen.de
authors.forename: L
authors.initials: L
authors.lastname: Möller
authors.forename: K
authors.initials: K
authors.lastname: Mann
mesh_terms: D000236:Adenoma / Q000150:complications / Q000532:radiotherapy; D000380:Agranulocytosis / Q000139:chemically induced; D013956:Antithyroid Agents / Q000008:administration & dosage; D005260:Female; D006044:Goiter, Nodular / Q000150:complications; D006111:Graves Disease / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D006980:Hyperthyroidism / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D008713:Methimazole / Q000008:administration & dosage* / Q000009:adverse effects; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000628:therapy; D011441:Propylthiouracil / Q000627:therapeutic use*; D013964:Thyroid Neoplasms / Q000150:complications; D013965:Thyroidectomy
chemical_list: D013956:Antithyroid Agents; D008713:Methimazole; D011441:Propylthiouracil
references.citation: Clin Endocrinol (Oxf). 2009 Oct;71(4):566-73
references.pmid: 19170704
references.citation: J Clin Endocrinol Metab. 2005 Dec;90(12):6472-9
references.pmid: 16204360
references.citation: J Clin Endocrinol Metab. 2010 Jan;95(1):186-93
references.pmid: 19906785
references.citation: Horm Metab Res. 2004 Feb;36(2):92-6
references.pmid: 15002058
references.citation: Clin Endocrinol (Oxf). 2010 Mar;72(3):292-6
references.pmid: 19744106
references.citation: Thyroid. 2009 Jul;19(7):673-4
references.pmid: 19583480
references.citation: Am J Cardiol. 2009 Feb 15;103(4):540-3
references.pmid: 19195517
references.citation: World J Surg. 2008 Jul;32(7):1269-77
references.pmid: 18327526
references.citation: Clin Invest Med. 2009 Apr 01;32(2):E158-65
references.pmid: 19331805
references.citation: J Urol. 2009 Mar;181(3):1273-80
references.pmid: 19185321
references.citation: Thyroid. 2009 Mar;19(3):219-25
references.pmid: 19265492
references.citation: Nat Rev Cardiol. 2010 Jan;7(1):5-6
references.pmid: 20019753
references.citation: Clin Chem Lab Med. 2009;47(9):1091-5
references.pmid: 19634982
references.citation: World J Surg. 2009 Sep;33(9):1971-7
references.pmid: 19575141
references.citation: Eur J Endocrinol. 2009 Nov;161(5):779-86
references.pmid: 19671706
references.citation: J Surg Res. 2000 May 15;90(2):161-5
references.pmid: 10792958
references.citation: World J Surg. 2010 Jun;34(6):1261-4
references.pmid: 20033406
references.citation: Eur J Clin Invest. 2009 Jan;39(1):51-7
references.pmid: 19087129
references.citation: J Clin Endocrinol Metab. 2002 Aug;87(8):3583-9
references.pmid: 12161479
references.citation: J Clin Endocrinol Metab. 2007 Jun;92(6):2157-62
references.pmid: 17389704
references.citation: Eur Arch Otorhinolaryngol. 2010 Jun;267(6):955-60
references.pmid: 20035341
references.citation: Acta Radiol. 2007 Mar;48(2):186-92
references.pmid: 17354140
references.citation: Am J Med Sci. 2009 Apr;337(4):225-32
references.pmid: 19402203
references.citation: Eur Radiol. 2008 Jun;18(6):1244-50
references.pmid: 18286289
references.citation: Br J Clin Pharmacol. 2009 Oct;68(4):609-17
references.pmid: 19843064
references.citation: Endocr J. 2007 Feb;54(1):39-43
references.pmid: 17053291
references.citation: Thyroid. 2009 Jun;19(6):559-63
references.pmid: 19445623
references.citation: Med Klin (Munich). 2009 May 15;104(5):343-8
references.pmid: 19444414
references.citation: J Clin Endocrinol Metab. 1986 Jul;63(1):125-8
references.pmid: 3011835
references.citation: BMJ. 2007 Mar 10;334(7592):514
references.pmid: 17309884
references.citation: Cochrane Database Syst Rev. 2010 Jan 20;(1):CD003420
references.pmid: 20091544
references.citation: J Clin Endocrinol Metab. 2009 Dec;94(12):4984-91
references.pmid: 19850691
references.citation: J Clin Endocrinol Metab. 2009 Jun;94(6):1881-2
references.pmid: 19401361
references.citation: J Clin Endocrinol Metab. 2008 May;93(5):1815-9
references.pmid: 18270255
references.citation: J Am Coll Cardiol. 2009 Sep 15;54(12):1089-95
references.pmid: 19744618